Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290706
Status:
TERMINATED
Last Update Posted:
2019-05-28
First Post:
2006-02-09
Brief Title:
A Phase III Trial of VELCADE Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkins Lymphoma
Sponsor:
Northwestern University
Organization:
Northwestern University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent mycosis fungoidesSezary syndrome | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |